Civitas Therapeutics
RECENT NEWS
Civitas Therapeutics Appoints Mark Iwicki President and Chief Executive Officer
LATEST NEWS
Civitas Therapeutics Announces Positive Phase 2b Results for CVT-301, Inhaled Levodopa for the Treatment of Parkinson's Disease
© 2014 CIVITAS THERAPEUTICS|190 EVERETT AVENUE, CHELSEA MA 02150|MAIN 617.660.4110|FAX 617.884.3990